Skip to main content
logo
Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
38.89
+1.16 (3.07%)
At close: Sep 11, 2026, 4:00 PM EDT
38.50
-0.39 (-1.00%)
After-hours: Sep 11, 2026, 7:55 PM EDT

Definium Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,2261,31951014783590
Market Cap Growth
636.09%158.44%247.80%77.54%-85.99%-82.89%
Enterprise Value
4,1781,15123943-72444
Last Close Price
38.8913.396.963.662.2020.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.693.972.111.880.553.89
P/TBV Ratio
5.814.222.302.540.654.73

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.120.090.18--
Net Debt / Equity Ratio
-1.14-1.12-1.04-1.09-0.94-0.88
Net Debt / EBITDA Ratio
-2.232.42-2.141.43
Quick Ratio
6.906.177.053.097.9412.83
Current Ratio
6.956.297.253.228.1613.18
Return on Equity (ROE)
-64.09%-64.06%-68.01%-83.59%-37.54%-81.78%
Return on Assets (ROA)
-20.64%-28.01%-30.44%-39.84%-24.82%-47.63%
Return on Capital Employed (ROCE)
-23.80%-44.50%-39.50%-101.70%-43.60%-60.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.77%-13.93%-21.29%-65.24%-68.71%-15.76%
Buyback Yield / Dilution
-22.22%-26.78%-79.94%-26.90%-12.71%-54.25%